CellaVision AB: Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 5, 2017
CellaVision AB: Interim report January-March 2017
CellaVision presents the first quarter 2017 on May 4 at 11:00 CET
CellaVisions 2016 Annual report now available
CellaVision quantifies the outlook for the first quarter of 2017. Sales exceeding SEK 93 million in the first quarter of 2017
CellaVision AB: Notice of 2017 Annual General Meeting of CellaVision (publ)
CellaVision AB: Year-end bulletin 2016, Strong close to 2016 and a very strong start of 2017
CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors
CellaVision AB: CellaVision presents the year-end bulletin for 2016 on February 7 at 10:00 CET
CellaVision AB: Interim report January-September 2016
CellaVision AB: Presents the third quarter 2016 on October 27 at 11:00 CET
CellaVision AB: Interim Report January-June 2016
CellaVision AB presents the second quarter 2016 on July 15 at 11:00 CET
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 4, 2016
CellaVision AB: Interim report January-March 2016
CellaVision AB presents the first quarter of 2016 on May 3 at 10:00 CET
CellaVision AB: CellaVision's 2015 Annual Report now available
CellaVision AB: Notice of Annual General Meeting of CellaVision (publ)
CellaVision AB: Nomination Committee proposal of Chairman succession and re-election of members to the Board of Directors.
CellaVision AB : Year-end bulletin 2015
CellaVision AB: Interim Report January-September 2015
CellaVision presents the third quarter 2015 on November 9 at 10:00 CET
CellaVision AB: Interim Report January-June 2015
CellaVision AB revises its financial target for operating margin from 15% to 20% over an economic cycle.
CellaVision has received a follow-up order in excess of SEK 30 million from the veterinary market.
CellaVision presents the second quarter 2015 on July 17 at 10:00 CET
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 6, 2015
CellaVision AB: Interim report January-March 2015
CellaVision's 2014 Annual Report now available
Notice of 2015 Annual General Meeting in CellaVision AB
CellaVision Year-end bulletin 2014
CellaVision AB receives its first major order for the veterinary market
CellaVision AB: Interim Report January-September 2014
CellaVision AB : Zlatko Rihter appointed new President/CEO for CellaVision
CellaVision AB: Interim Report January-June 2014
CellaVision acquires a new technology platform
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 7, 2014
Yvonne Mårtensson will leave her position as President/CEO of CellaVision at year end 2014.
CellaVision AB: Interim report January-March 2014
CellaVision strengthens its product portfolio with two new products
CellaVision's 2013 Annual Report now available
Notice of 2014 Annual General Meeting in CellaVision AB
CellaVision Year-end bulletin 2013
CellaVision revises outlook for the full year: Sales growth in 2013
CellaVision AB: Interim report January - September 2013
CellaVision awarded Best Optics and Photonics Company
CellaVision signs Term Sheet with potential Chinese distribution partner
CellaVision AB: Interim report January - June 2013
CellaVision appoints new heads of Quality Assurance and Scientific Affairs
Sweden's Equalis invests in CellaVision's new product for external quality assurance of laboratory tests in hematology
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 24, 2013
CellaVision AB: Interim report January - March 2013
CellaVision appoints new CFO
CellaVision and Sysmex announce a jointly-developed product for hematology labs
CellaVision and Beckman Coulter enhance partnership by adding EMEA to their global distribution agreement
CellaVision's 2012 Annual Report now available
Notice of Annual General Meeting in CellaVision AB, April 24, 2013
CellaVision launches a new product for proficiency testing
CellaVision adds another distribution agreement for the European market
CellaVision AB: Year-end bulletin 2012
CellaVision strengthens its organization with new positions and new employees
CellaVision AB: Interim report January - September 2012
CellaVision Announces Distribution Agreement with Siemens for Digital Microscopy Hematology Solutions
CellaVision receives first order from the Veterinary market
CellaVision AB: Interim report January - June 2012
CellaVision appoints Acting CFO
New President of CellaVision North America
CellaVision introduces CellaVision® Image Capture System for smaller laboratories within a hospital network
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 2, 2012
CellaVision reinforces management team with a Vice President of Sales & Business Development
CellaVision AB Interim report: January - March 2012
CellaVision's 2011 Annual Report now available
CellaVision AB: Notice of Annual General Meeting in CellaVision AB (publ), May 2, 2012
CellaVision AB: Year-end bulletin 2011
CellaVision launches digital cell morphology system into the North American Veterinary market
CellaVision AB (publ) Interim report January - September 2011
FDA clears CellaVision® Body Fluid Application for the CellaVision® DM1200 Cell Morphology System
CellaVision receives important order from a leading Canadian laboratory
CellaVision delivers 1,000th digital cell morphology system to Southampton General Hospital, England
CellaVision AB (publ) Interim report: January 1 - June 30, 2011
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 26, 2011
CellaVision AB (publ) Interim report: January 1 - March 31 2011
CellaVision's 2010 Annual Report now available
Notice of Annual General Meeting in CellaVision AB (publ), April 26, 2011
CellaVisions new product concept for hospital networks enters the evaluation phase
CELLAVISION AB (publ) - Year-End Bulletin 2010
CellaVision introduces an iPhone/iPod Touch Application for hematology competency
CellaVision launches scientific blog for the clinical laboratory industry
CellaVision reinforces management team with a Chief Operating Officer
Unilabs streamlines laboratory operations with analyzers from CellaVision
Tredje AP-fonden new major shareholder in CellaVision
CELLAVISION AB (publ) Interim report for the period January 1 - September 30, 2010
CELLAVISION AB (publ) Interim report for the period January 1-June 30, 2010
CellaVision has been approved for listing on NASDAQ OMX Stockholm
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on 29 April 2010
CELLAVISION AB (publ) - Interim report for the period January 1 - March 31, 2010
CellaVision announces new reporting date for the 2010 January - March interim report
CellaVision's 2009 Annual Report now available
Notice of Annual General Meeting in CellaVision AB (publ), April 29, 2010
CellaVision and Sysmex enhance partnership by signing a global distribution agreement
CELLAVISION AB (publ) - Year-End Bulletin 2009
CellaVision to apply for listing on NASDAQ OMX Stockholm, Small Cap
CellaVision expands sales channels in the US
Canadian Health Authority invests in CellaVision's newest analyzer
CellaVision's new analyzer receives FDA clearance for the US market
CellaVision AB - Interim report for the period January 1 - September 30, 2009
New CellaVision® DM1200 analyzer approved for sales in Canada
CellaVision's image analysis becomes gold standard at labs in Swedish county council
CellaVision evaluates new product for the veterinary market
CellaVision's CEO Yvonne Mårtensson wins the 2009 Biotech Builder Award
CellaVision's new analyzer CellaVision® DM1200 presented at AACC in the USA
CELLAVISION AB (publ) Interim report for the period January 1 - June 30, 2009
CellaVision wins SwedenBio Award
CellaVision launches new analyzer for medium-sized hospitals
CellaVision AB: Resolutions from Annual General Meeting 2009
CELLAVISION AB (publ) - Interim report for the period January 1 - March 31, 2009
CellaVision names President of CellaVision North America
CellaVision receives first order in Japan
Notice of Annual General Meeting in CellaVision AB (publ), April 27 2009
CELLAVISION AB (publ) - Year-End Bulletin 2008
CellaVision AB qualified for trade on the new NASDAQ OMX First North Premier
CellaVision supports Medical Technology education across the U.S. and Canada
New Body Fluid Application for the CellaVision DM96 now cleared for sale in the US
CellaVision's US subsidiary receives strategically important orders
CELLAVISION AB (publ) Interim report for the period January 1 - September 30, 2008
CellaVision and Sysmex Europe extend exclusive distribution agreement for the CellaVision® DM products
CellaVision receives the first Canadian orders for the new body fluid application
Canadian reference laboratory chooses CellaVision for digital image analysis
CellaVision initiates marketing of its analyzers into the Japanese market
CELLAVISION AB (publ) Interim report for the period January 1 - June 30, 2008
CellaVision receives first order from China
CellaVision appoints new R&D Manager
Resolutions from CellaVision AB:s (publ), 556500-0998, Annual General Meeting (AGM) on April 23, 2008
CELLAVISION AB (publ) Interim report for the period January 1 - March 31, 2008
Notice of annual general meeting in CellaVision AB (publ), April 23 2008
CellaVision establishes subsidiary in Japan
CELLAVISION AB (publ) - Year-End Bulletin 2007
CellaVision prolongs cooperation with Kitron
CellaVision analyzer approved for sale in Taiwan
CellaVision expands the utility of the CellaVision DM96 digital morphology system
CellaVision's analyzer important tool in innovative telediagnostic project in Germany
CELLAVISION AB (publ) Interim report for the period January 1 - September 30, 2007
CellaVision aims at the Japanese market
CellaVision AB (publ) Interim report for the period 1 January - 30 June 2007
CellaVision's new application for analysis of body fluids pre-launched in the USA
CellaVision appoints new CFO
CellaVision AB - trading on First North will commence on May 28
Outline of CellaVision AB's Annual General Meeting (AGM) 2007
CellaVision AB (publ) Quarterly Report 1, 2007
CellaVision's largest deal ever in the Nordic Region - delivers products to Karolinska University Laboratory in Stockholm
CellaVision Annual Report 2006
CellaVision (publ) Financial Report Quarter 4, 2006
CellaVision receives the first order for a digital cell morphology system from St. Michael's Hospital, Toronto
CellaVision, Sysmex Europe and Sysmex America extend distribution agreement for CellaVision(TM) DM-products
Financial Report - Quarter 3 - 2006
CellaVision AB (publ) Financial Report Quarter 2, 2006
Outline of CellaVision AB:s (publ), 556500-0998, Annual General Meeting
CellaVision AB (publ) Financial Report - Quarter 1 - 2006
CellaVision receives certification to Quality System Standard: ISO 13485:2003
CellaVision Annual Report 2005
CellaVision AB launches new software for blood cell proficiency testing and education.
CellaVision, Lund, Sweden receives FDA clearance for the CellaVision(TM)DM96 Digital Cell Morphology System.
CellaVision celebrates its 10th patented invention
Strong performance at yearend 2001 by CellaVision - Rigshospitalet in Copenhagen becomes new reference customer
Directed new share issue implemented in CellaVision
CellaVision establishes U.S. presence by acquiring Triangle Imaging Inc.
CellaVision and Sysmex sign distribution agreement
CellaVision has completed the first sale of DiffMaster(TM)
CellaVision, Lund, Sweden has obtained FDA clearance to introduce its DiffMaster(TM) Octavia, an in-vitro diagnostic device, on the U.S. market.
CellaVision signs Letter of Intent with Sysmex

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analysts

ABG Sundal Collier AB
Sten Gustafsson
+46 8 566 286 93